[The development of the anti-phospholipase A2 antibody response in horses inoculated with venom for the production of polyvalent antisnake serum in Costa Rica].

The research article focuses on studying the development of anti-phospholipase A2 antibody response in horses after they were given venom from Bothrops asper, for the purpose of creating an anti-snake serum. The researchers analyzed the general condition of the horses as well as the immune response.

Objective of the Study

• The study aimed to examine the development of an antibody (immune) response against the phospholipase A2 activity of Bothrops asper venom in horses.
• The researchers also monitored the general health condition of the horses throughout the immunization schedule.

Study Procedure and Findings

• There was a large individual (horse to horse) variability in the immune response.
• Most of the horses reached the highest neutralizing titer (measurement of the antibodies in the blood) after being injected with doses of venom of 30 mg and 50 mg.
• For horses that had previously been immunized and were subjected to a second immunization, the highest titer was observed 16-22 days after the venom inoculation.

Health Impact on the Horses

• Only mild alterations were observed in the general condition of the horses due to venom inoculation.
• However, some horses developed local abscesses, fistulae, and areas of fibrosis at the injection spot.

Suggested Recommendation

• Given the significant individual variability noted in the study, the research proposes that the immune response in horses that are used for antivenom production should be evaluated on an individual basis. This is rather than using a pool of serum samples from multiple horses. This ensures that production is optimal and efficient.